{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:30Z","timestamp":1789632390694,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Huzhou Science and Technology Bureau","award":["2021GY07"],"award-info":[{"award-number":["2021GY07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05136-x","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:21:35Z","timestamp":1777346495000},"page":"4077-4091","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-derived extracellular vesicles exert promotional effects on metastasis in renal cell carcinoma through the delivery of microRNA-671-5p"],"prefix":"10.1007","volume":"58","author":[{"given":"Xiaohui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"5136_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfae036","volume":"39","author":"L Cirillo","year":"2024","unstructured":"Cirillo L, Innocenti S, Becherucci F (2024) Global epidemiology of kidney cancer. Nephrol Dial Transplant 39:920\u2013928","journal-title":"Nephrol Dial Transplant"},{"key":"5136_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2024.101335","volume":"101","author":"D Xie","year":"2025","unstructured":"Xie D, Li G, Zheng Z, Zhang X, Wang S, Jiang B et al (2025) The molecular code of kidney cancer: a path of discovery for gene mutation and precision therapy. Mol Aspects Med 101:101335","journal-title":"Mol Aspects Med"},{"key":"5136_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413239","author":"V Schiavoni","year":"2024","unstructured":"Schiavoni V, Emanuelli M, Milanese G, Galosi AB, Pompei V, Salvolini E et al (2024) Nrf2 signaling in renal cell carcinoma: a potential candidate for the development of novel therapeutic strategies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms252413239","journal-title":"Int J Mol Sci"},{"key":"5136_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121721","author":"K Jozwik-Plebanek","year":"2024","unstructured":"Jozwik-Plebanek K, Saracyn M, Kolodziej M, Kaminska O, Durma AD, Madra W et al (2024) Theranostics in renal cell carcinoma-a step towards new opportunities or a dead end-a systematic review. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph17121721","journal-title":"Pharmaceuticals (Basel)"},{"key":"5136_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1212101","volume":"14","author":"Y Lu","year":"2023","unstructured":"Lu Y, Zhang M, Zhou J, Liu X, Wang L, Hu X et al (2023) Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist. Front Immunol 14:1212101","journal-title":"Front Immunol"},{"key":"5136_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120216","volume":"289","author":"J Rezaie","year":"2022","unstructured":"Rezaie J, Ahmadi M, Ravanbakhsh R, Mojarad B, Mahbubfam S, Shaban SA et al (2022) Tumor-derived extracellular vesicles: the metastatic organotropism drivers. Life Sci 289:120216","journal-title":"Life Sci"},{"key":"5136_CR7","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8138","author":"C Jin","year":"2021","unstructured":"Jin C, Shi L, Li K, Liu W, Qiu Y, Zhao Y et al (2021) Mechanism of tumor\u2011derived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1. Oncol Rep. https:\/\/doi.org\/10.3892\/or.2021.8138","journal-title":"Oncol Rep"},{"key":"5136_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/ncb3094","volume":"17","author":"MY Fong","year":"2015","unstructured":"Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J et al (2015) Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 17:183\u2013194","journal-title":"Nat Cell Biol"},{"key":"5136_CR9","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1007\/s00210-024-03121-8","volume":"397","author":"A Ayed","year":"2024","unstructured":"Ayed A (2024) The role of natural products versus miRNA in renal cell carcinoma: implications for disease mechanisms and diagnostic markers. Naunyn Schmiedebergs Arch Pharmacol 397:6417\u20136437","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5136_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4149\/neo_2019_190217N135","volume":"67","author":"XG Chi","year":"2020","unstructured":"Chi XG, Meng XX, Ding DL, Xuan XH, Chen YZ, Cai Q et al (2020) HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling. Neoplasma 67:46\u201353","journal-title":"Neoplasma"},{"key":"5136_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3674","volume":"26","author":"H Ali","year":"2024","unstructured":"Ali H, Malik MZ, Abu-Farha M, Abubaker J, Cherian P, Nizam R et al (2024) Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease. J Gene Med 26:e3674","journal-title":"J Gene Med"},{"key":"5136_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1012179","volume":"10","author":"HC Zheng","year":"2022","unstructured":"Zheng HC, Xue H, Jiang HM (2022) The roles of ING5 in cancer: a tumor suppressor. Front Cell Dev Biol 10:1012179","journal-title":"Front Cell Dev Biol"},{"key":"5136_CR13","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.7150\/ijbs.97720","volume":"20","author":"YJ Fan","year":"2024","unstructured":"Fan YJ, Pan FZ, Cui ZG, Zheng HC (2024) The antitumor and Sorafenib-resistant reversal effects of Ursolic Acid on hepatocellular carcinoma via targeting ING5. Int J Biol Sci 20:4190\u20134208","journal-title":"Int J Biol Sci"},{"key":"5136_CR14","volume":"2022","author":"B Wang","year":"2022","unstructured":"Wang B, Wang Y, Wang X, Gu J, Wu W, Wu H et al (2022) Extracellular vesicles carrying miR-887-3p promote breast cancer cell drug resistance by targeting BTBD7 and activating the Notch1\/Hes1 signaling pathway. Dis Markers 2022:5762686","journal-title":"Dis Markers"},{"key":"5136_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-019-0997-z","volume":"18","author":"L Wang","year":"2019","unstructured":"Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q et al (2019) CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p. Mol Cancer 18:86","journal-title":"Mol Cancer"},{"key":"5136_CR16","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.7150\/jca.20234","volume":"8","author":"YZ Ge","year":"2017","unstructured":"Ge YZ, Xu LW, Zhou CC, Lu TZ, Yao WT, Wu R et al (2017) A BAP1 mutation-specific MicroRNA signature predicts clinical outcomes in clear cell renal cell carcinoma patients with wild-type BAP1. J Cancer 8:2643\u20132652","journal-title":"J Cancer"},{"key":"5136_CR17","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.7150\/ijbs.70289","volume":"18","author":"W Zhang","year":"2022","unstructured":"Zhang W, Zheng X, Yu Y, Zheng L, Lan J, Wu Y et al (2022) Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway. Int J Biol Sci 18:3209\u20133222","journal-title":"Int J Biol Sci"},{"key":"5136_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biology12060877","author":"I Mastrolia","year":"2023","unstructured":"Mastrolia I, Catani V, Oltrecolli M, Pipitone S, Vitale MG, Masciale V et al (2023) Chasing the role of miRNAs in RCC: from free-circulating to extracellular-vesicle-derived biomarkers. Biology. https:\/\/doi.org\/10.3390\/biology12060877","journal-title":"Biology"},{"key":"5136_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713085","author":"F Sepulveda","year":"2023","unstructured":"Sepulveda F, Mayorga-Lobos C, Guzman K, Duran-Jara E, Lobos-Gonzalez L (2023) EV-miRNA-mediated intercellular communication in the breast tumor microenvironment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713085","journal-title":"Int J Mol Sci"},{"key":"5136_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115138","volume":"214","author":"A Blandino","year":"2025","unstructured":"Blandino A, Scherer D, Boekstegers F, Rounge TB, Langseth H, Roessler S et al (2025) Small-RNA sequencing reveals potential serum biomarkers for gallbladder cancer: results from a three-stage collaborative study of large European prospective cohorts. Eur J Cancer 214:115138","journal-title":"Eur J Cancer"},{"key":"5136_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022041749","volume":"32","author":"X Chen","year":"2022","unstructured":"Chen X, Luo J, Gao S, Jiang J, Yang B, Zhang Z (2022) miR-671-5p promotes cell proliferation, invasion, and migration in hepatocellular carcinoma through targeting ALDH2. Crit Rev Eukaryot Gene Expr 32:73\u201382","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"5136_CR22","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1111\/cas.15820","volume":"114","author":"K Guo","year":"2023","unstructured":"Guo K, Shi J, Tang Z, Lai C, Liu C, Li K et al (2023) Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR-671-5p\/LGALS3BP\/NF-kappaB axis. Cancer Sci 114:2907\u20132919","journal-title":"Cancer Sci"},{"key":"5136_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10616-021-00506-y","volume":"74","author":"Y Yang","year":"2022","unstructured":"Yang Y, Yang N, Jiang J (2022) Exosomal circ_PTPRA inhibits tumorigenesis and promotes radiosensitivity in colorectal cancer by enriching the level of SMAD4 via competitively binding to miR-671-5p. Cytotechnology 74:51\u201364","journal-title":"Cytotechnology"},{"key":"5136_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9133658","volume":"2022","author":"X Li","year":"2022","unstructured":"Li X, Li X, Zhang B, He B (2022) The role of cancer stem cell-derived exosomes in cancer progression. Stem Cells Int 2022:9133658","journal-title":"Stem Cells Int"},{"key":"5136_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00993","volume":"11","author":"H Ishii","year":"2020","unstructured":"Ishii H, Kaneko S, Yanai K, Aomatsu A, Hirai K, Ookawara S et al (2020) MicroRNAs in podocyte injury in diabetic nephropathy. Front Genet 11:993","journal-title":"Front Genet"},{"key":"5136_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3724\/abbs.2023074","volume":"55","author":"J Yang","year":"2023","unstructured":"Yang J, Liu X, Sun Y, Zhang X, Zhao Y, Zhang H et al (2023) ING5 overexpression upregulates miR-34c-5p\/Snail1 to inhibit EMT and invasion of lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 55:809\u2013817","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"5136_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12943-017-0658-z","volume":"16","author":"S Cui","year":"2017","unstructured":"Cui S, Liao X, Ye C, Yin X, Liu M, Hong Y et al (2017) ING5 suppresses breast cancer progression and is regulated by miR-24. Mol Cancer 16:89","journal-title":"Mol Cancer"},{"key":"5136_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12935-020-01200-3","volume":"20","author":"H Xin","year":"2020","unstructured":"Xin H, Wang C, Chi Y, Liu Z (2020) MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5. Cancer Cell Int 20:119","journal-title":"Cancer Cell Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05136-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05136-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:53:19Z","timestamp":1789631599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05136-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":28,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5136"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05136-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Animal Ethics Committee of Huzhou Central Hospital reviewed and ratified every animal experiment. The animal experiments have been carried out in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}